Dr. Betina J. Lew is a Board Certified (DABT) and European Registered (ERT) Toxicologist with broad experience in Medical Devices and Consumer Goods Industry. She is currently an Associate Director of Toxicology and Biocompatibility at Johnson&Johnson (J&J) where she manages the Ethicon Inc (Somerville, NJ) team and oversees the safety of a diverse portfolio which includes the wound closure and healing, biosurgery and mentor breast implants business units. Betina manages the team and provides scientific input in all aspects of the toxicological assessments of the medical devices and biologics. She worked as a Toxicologist and Safety Manager in other companies (such as Procter and Gamble and Reckitt Benckiser). Dr. Lew was a Postdoctoral Trainee in Toxicology at the Department of Environmental Medicine, University of Rochester (NY) for more than four years. She earned a PhD through a joint program from São Paulo State and Michigan State University, a M.S. from The Hebrew University of Jerusalem (Israel) and a B.S. from São Paulo State University.
Since 2006, Dr. Lew has been an active member of the SOT and served on several committees. Currently the Co-Chair (2020-2021) and Incoming Chair (2021– 2022) of the Membership committee, which she was elected member in 2019. She was President of Women in Toxicology (WIT, 2016-2018), Councilor of Risk Assessment Specially Session (RASS, 2016-2019). She was a member of CRAD (2013-2016), President of the Hispanic Organization of Toxicologists (HOT) from 2011 – 2013, their Councilor (2009–2011) and Chair of the Awards and Education committees (2010–2012). She has also served as the Chair (2008–2010) for the Postdoctoral Assembly (PDA).
Throughout her career, Dr. Lew received many awards and grants support. Betina is a strong supporter of trainees at the SOT. She co-chaired numerous sessions focused on career development of younger toxicologists and mentored several students and postdocs.